Semin Plast Surg 2024; 38(01): 061-068
DOI: 10.1055/s-0043-1778043
Review Article

Perioperative Opioid-Related Harms: Opportunities to Minimize Risk

Dominic Alessio-Bilowus
1   Section of Plastic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, Michigan
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
,
Alexandra O. Luby
1   Section of Plastic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, Michigan
3   Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan
,
Samantha Cooley
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
,
Sarah Evilsizer
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
,
Elizabeth Seese
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
,
Mark Bicket
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
4   Division of Pain Research, Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan
,
Jennifer F. Waljee
1   Section of Plastic Surgery, Department of Surgery, Michigan Medicine, Ann Arbor, Michigan
2   Opioid Prescribing Engagement Network, Ann Arbor, Michigan
3   Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan
› Author Affiliations

Abstract

Although substantial attention has been given to opioid prescribing in the United States, opioid-related mortality continues to climb due to the rising incidence and prevalence of opioid use disorder. Perioperative care has an important role in the consideration of opioid prescribing and the care of individuals at risk for poor postoperative pain- and opioid-related outcomes. Opioids are effective for acute pain management and commonly prescribed for postoperative pain. However, failure to align prescribing with patient need can result in overprescribing and exacerbate the flow of unused opioids into communities. Conversely, underprescribing can result in the undertreatment of pain, complicating recovery and impairing well-being after surgery. Optimizing pain management can be particularly challenging for individuals who are previously exposed to opioids or have critical risk factors, including opioid use disorder. In this review, we will explore the role of perioperative care in the broader context of the opioid epidemic in the United States, and provide considerations for a multidisciplinary, comprehensive approach to perioperative pain management and optimal opioid stewardship.

Supplementary Material



Publication History

Article published online:
18 February 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Upp LA, Waljee JF. The opioid epidemic. Clin Plast Surg 2020; 47 (02) 181-190
  • 2 Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief 2022; (457) 1-8
  • 3 Data Overview | Opioids | CDC. Published August 8, 2023. Accessed September 12, 2023 at: https://www.cdc.gov/opioids/data/index.html
  • 4 Vu JV, Lin LA. Opioid overdose-the surgeon's role. Ann Surg 2018; 268 (01) 32-34
  • 5 Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 2016; 374 (02) 154-163
  • 6 Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg 2017; 152 (11) 1066-1071
  • 7 U.S. Opioid Dispensing Rate Maps | Drug Overdose | CDC Injury Center. Published October 19, 2022. Accessed September 12, 2023 at: https://www.cdc.gov/drugoverdose/rxrate-maps/index.html
  • 8 Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–United States, 2016. JAMA 2016; 315 (15) 1624-1645
  • 9 Larach DB, Waljee JF, Hu HM. et al. Patterns of initial opioid prescribing to opioid-naive patients. Ann Surg 2020; 271 (02) 290-295
  • 10 Brummett CM, England C, Evans-Shields J. et al. Health care burden associated with outpatient opioid use following inpatient or outpatient surgery. J Manag Care Spec Pharm 2019; 25 (09) 973-983
  • 11 Howard R, Fry B, Gunaseelan V. et al. Association of opioid prescribing with opioid consumption after surgery in Michigan. JAMA Surg 2019; 154 (01) e184234
  • 12 Howard R, Brown CS, Lai YL. et al. Postoperative opioid prescribing and new persistent opioid use: the risk of excessive prescribing. Ann Surg 2023; (06) e1225-e1231
  • 13 Santosa KB, Priest CR, Oliver JD. et al. Long-term health outcomes of new persistent opioid use after surgery among Medicare beneficiaries. Ann Surg 2023; 278 (03) e491-e495
  • 14 Lee JS, Vu JV, Edelman AL. et al. Health care spending and new persistent opioid use after surgery. Ann Surg 2020; 272 (01) 99-104
  • 15 Santosa KB, Hu HM, Brummett CM. et al. New persistent opioid use among older patients following surgery: a Medicare claims analysis. Surgery 2020; 167 (04) 732-742
  • 16 Santosa KB, Lai YL, Brummett CM. et al. Higher amounts of opioids filled after surgery increase risk of serious falls and fall-related injuries among older adults. J Gen Intern Med 2020; 35 (10) 2917-2924
  • 17 Brummett CM, Waljee JF, Goesling J. et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 2017; 152 (06) e170504
  • 18 Harbaugh CM, Vargas G, Streur CS. et al. Eliminating unnecessary opioid exposure after common children's surgeries. JAMA Surg 2019; 154 (12) 1154-1155
  • 19 Harbaugh CM, Lee JS, Hu HM. et al. Persistent opioid use among pediatric patients after surgery. Pediatrics 2018; 141 (01) e20172439
  • 20 Chua KP, Brummett CM, Conti RM, Bohnert A. Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults. JAMA Pediatr 2020; 174 (02) 141-148
  • 21 Santosa KB, Wang CS, Hu HM. et al. Opioid coprescribing with sedatives after implant-based breast reconstruction. Plast Reconstr Surg 2022; 150 (06) 1224e-1235e
  • 22 Delaney LD, Bicket MC, Hu HM. et al. Opioid and benzodiazepine prescribing after COVID-19 hospitalization. J Hosp Med 2022; 17 (07) 539-544
  • 23 Waljee JF, Gunaseelan V, Bicket MC, Brummett CM, Chua KP. Safety and distribution of opioid prescribing by U.S. surgeons. Ann Surg 2023; 277 (06) 944-951
  • 24 Howard R, Brown CS, Lai YL. et al. The association of postoperative opioid prescriptions with patient outcomes. Ann Surg 2022; 276 (06) e1076-e1082
  • 25 Fry BT, Howard RA, Gunaseelan V. et al. Association of postoperative opioid prescription size and patient satisfaction. Ann Surg 2022; 276 (06) e1064-e1069
  • 26 Lee JS, Hu HM, Brummett CM. et al. Postoperative opioid prescribing and the pain scores on hospital consumer assessment of healthcare providers and systems survey. JAMA 2017; 317 (19) 2013-2015
  • 27 Sekhri S, Arora NS, Cottrell H. et al. Probability of opioid prescription refilling after surgery: does initial prescription dose matter?. Ann Surg 2018; 268 (02) 271-276
  • 28 Howard R, Waljee J, Brummett C, Englesbe M, Lee J. Reduction in opioid prescribing through evidence-based prescribing guidelines. JAMA Surg 2018; 153 (03) 285-287
  • 29 Howard R, Alameddine M, Klueh M. et al. Spillover effect of evidence-based postoperative opioid prescribing. J Am Coll Surg 2018; 227 (03) 374-381
  • 30 Vu JV, Howard RA, Gunaseelan V, Brummett CM, Waljee JF, Englesbe MJ. Statewide implementation of postoperative opioid prescribing guidelines. N Engl J Med 2019; 381 (07) 680-682
  • 31 Brown CS, Vu JV, Howard RA. et al. Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system. BMJ Qual Saf 2021; 30 (03) 251-259
  • 32 Opioid Prescribing – Michigan OPEN. Accessed October 20, 2023 at: https://michigan-open.org/prescribing-recommendations/
  • 33 Hallway A, Vu J, Lee J. et al. Patient satisfaction and pain control using an opioid-sparing postoperative pathway. J Am Coll Surg 2019; 229 (03) 316-322
  • 34 Anderson M, Hallway A, Brummett C, Waljee J, Englesbe M, Howard R. Patient-reported outcomes after opioid-sparing surgery compared with standard of care. JAMA Surg 2021; 156 (03) 286-287
  • 35 Howard R, Ryan A, Hu HM. et al. Evidence-based opioid prescribing guidelines and new persistent opioid use after surgery. Ann Surg 2023; 278 (02) 216-221
  • 36 Howard R, Vu J, Lee J, Brummett C, Englesbe M, Waljee J. A pathway for developing postoperative opioid prescribing best practices. Ann Surg 2020; 271 (01) 86-93
  • 37 Mauck MC, Zhao Y, Goetzinger AM. et al. Incidence of persistent opioid use following traumatic injury. Reg Anesth Pain Med 2023; rapm-2022-103662 DOI: 10.1136/rapm-2022-103662.
  • 38 Santosa KB, Wang CS, Hu HM, Brummett CM, Englesbe MJ, Waljee JF. Surgeon experience and opioid prescribing. Am J Surg 2020; 220 (04) 823-827
  • 39 Vu JV, Cron DC, Lee JS. et al. Classifying preoperative opioid use for surgical care. Ann Surg 2020; 271 (06) 1080-1086
  • 40 Katzman C, Harker EC, Ahmed R. et al. The association between preoperative opioid exposure and prolonged postoperative use. Ann Surg 2021; 274 (05) e410-e416
  • 41 Bicket MC, Gunaseelan V, Lagisetty P. et al. Association of opioid exposure before surgery with opioid consumption after surgery. Reg Anesth Pain Med 2022; 47 (06) 346-352
  • 42 Agarwal S, Shah A, Gunaseelan V. et al. New persistent opioid use after surgery in patients with a history of remote opioid use. Surgery 2022; 171 (06) 1635-1641
  • 43 Waljee JF, Cron DC, Steiger RM, Zhong L, Englesbe MJ, Brummett CM. Effect of preoperative opioid exposure on healthcare utilization and expenditures following elective abdominal surgery. Ann Surg 2017; 265 (04) 715-721
  • 44 Cron DC, Englesbe MJ, Bolton CJ. et al. Preoperative opioid use is independently associated with increased costs and worse outcomes after major abdominal surgery. Ann Surg 2017; 265 (04) 695-701
  • 45 Santosa KB, Lai YL, Oliver JD. et al. Preoperative opioid use and mortality after minor outpatient surgery. JAMA Surg 2020; 155 (12) 1169-1171
  • 46 Tang R, Santosa KB, Vu JV. et al. Preoperative opioid use and readmissions following surgery. Ann Surg 2022; 275 (01) e99-e106
  • 47 Instrument: TAPS Tool | NIDA CTN Common Data Elements. Accessed October 2, 2023 at: https://cde.nida.nih.gov/instrument/29b23e2e-e266-f095-e050-bb89ad43472f
  • 48 Gryczynski J, McNeely J, Wu LT. et al. Validation of the TAPS-1: a four-item screening tool to identify unhealthy substance use in primary care. J Gen Intern Med 2017; 32 (09) 990-996
  • 49 Akbar A, Rieck H, Roy S. et al. Patient-related acceptability of implementing preoperative screening for at-risk opioid and substance use. Pain Med 2023; 24 (08) 1014-1016
  • 50 Fernandez AC, Aslesen H, Golmirzaie G. et al. Patient responses to surgery-relevant screening for opioid and other risky substance use before surgery: a pretest-posttest study. Pain Med 2023; 24 (07) 896-899
  • 51 Fernandez AC, Waljee JF, Gunaseelan V, Brummett CM, Englesbe MJ, Bicket MC. Prevalence of unhealthy substance use and associated characteristics among patients presenting for surgery. Ann Surg 2022; 278 (04) e740-e744
  • 52 Sloss KR, Vargas G, Brummett CM. et al. Association of caregiver-reported education with locked storage and disposal of prescription opioids after children's surgery. J Pediatr Surg 2020; 55 (11) 2442-2447
  • 53 Brummett CM, Steiger R, Englesbe M. et al. Effect of an activated charcoal bag on disposal of unused opioids after an outpatient surgical procedure: a randomized clinical trial. JAMA Surg 2019; 154 (06) 558-561
  • 54 Lawrence AE, Carsel AJ, Leonhart KL. et al. Effect of drug disposal bag provision on proper disposal of unused opioids by families of pediatric surgical patients: a randomized clinical trial. JAMA Pediatr 2019; 173 (08) e191695
  • 55 Lin LA, Brummett CM, Waljee JF, Englesbe MJ, Gunaseelan V, Bohnert ASB. Association of opioid overdose risk factors and naloxone prescribing in US adults. J Gen Intern Med 2020; 35 (02) 420-427
  • 56 Guy Jr GP, Haegerich TM, Evans ME, Losby JL, Young R, Jones CM. Vital signs: pharmacy-based naloxone dispensing - United States, 2012-2018. MMWR Morb Mortal Wkly Rep 2019; 68 (31) 679-686
  • 57 Smart R, Geiger CK, Jones CM, Stein BD. An observational study of retail pharmacy naloxone prescriptions: differences across provider specialties and patient populations. J Gen Intern Med 2020; 35 (06) 1768-1775
  • 58 Dora-Laskey A, Kellenberg J, Dahlem CH. et al. Piloting a statewide emergency department take-home naloxone program: improving the quality of care for patients at risk of opioid overdose. Acad Emerg Med 2022; 29 (04) 442-455
  • 59 Jones CM, Shoff C, Hodges K. et al. Receipt of telehealth services, receipt and retention of medications for opioid use disorder, and medically treated overdose among Medicare beneficiaries before and during the COVID-19 pandemic. JAMA Psychiatry 2022; 79 (10) 981-992
  • 60 Palzes VA, Chi FW, Metz VE. et al. Overall and telehealth addiction treatment utilization by age, race, ethnicity, and socioeconomic status in California after COVID-19 policy changes. JAMA Health Forum 2023; 4 (05) e231018
  • 61 Lagisetty P, Bohnert A, Goesling J. et al. Care coordination for patients on chronic opioid therapy following surgery: a cohort study. Ann Surg 2020; 272 (02) 304-310
  • 62 Klueh MP, Hu HM, Howard RA. et al. Transitions of care for postoperative opioid prescribing in previously opioid-naïve patients in the USA: a retrospective review. J Gen Intern Med 2018; 33 (10) 1685-1691
  • 63 Hinds S, Miller J, Maccani M. et al. Patient risk screening to improve transitions of care in surgical opioid prescribing: a qualitative study of provider perspectives. Reg Anesth Pain Med 2022; 47 (08) 475-483
  • 64 Cron DC, Lee JS, Dupree JM. et al. Provider characteristics associated with outpatient opioid prescribing after surgery. Ann Surg 2020; 271 (04) 680-685
  • 65 Priest CR, Waljee JF, Bicket MC, Hu HM, Chua KP. Comparison of opioids prescribed by advanced practice clinicians vs surgeons after surgical procedures in the US. JAMA Netw Open 2023; 6 (01) e2249378
  • 66 Howard R, Hallway A, Santos-Parker J. et al. Optimizing postoperative opioid prescribing through quality-based reimbursement. JAMA Netw Open 2019; 2 (09) e1911619